Subsequent bioinformatics analyses revealed that COX‐2 was significantly overexpressed in GBM compared to both low‐grade gliomas and normal brain tissues, correlating with tumour aggressiveness. This evidence concerns the gene PTGS2 and central nervous system cancer.